IPO registrations (S-1, F-1) · Registrants
ALDAGEN INC
- SEC CIK
- 1128188 · filings on EDGAR ↗
- Former names
- STEMCO BIOMEDICAL INC (2002–2005)
- Registration
- Form S-1, first filed 2008-05-09, last 2010-07-02; 2 initial registrations, 5 amendments
- Outcome
- Withdrawal requested 2008-10-07
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 2810 MERIDIAN PARKWAY SUITE 148, Durham, NC 27713
- EIN
- 56-2185054
- EDGAR entity type
- other
Offering terms
- Listing
- Nasdaq under the symbol ALDH.U
- Lead underwriters
- Ladenburg Thalmann
- Syndicate
- Boenning & Scattergood, Inc
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: ALDAGEN, INC. EXACT (EIN (EXACT))
- Form D issuer: ALDAGEN INC EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-05-09 | S-1 | S-1 (registration) | ALDAGEN INC | 0001193125-08-109922 ↗ |
| 2008-06-18 | S-1/A | S-1/A (amendment) | ALDAGEN INC | 0001193125-08-136051 ↗ |
| 2008-10-07 | RW | RW (withdrawal request) | ALDAGEN INC | 0001193125-08-207347 ↗ |
| 2009-10-28 | S-1 | S-1 (registration) | ALDAGEN INC | 0001193125-09-215575 ↗ |
| 2009-12-09 | S-1/A | S-1/A (amendment) | ALDAGEN INC | 0001193125-09-249978 ↗ |
| 2010-05-05 | S-1/A | S-1/A (amendment) | ALDAGEN INC | 0001193125-10-109129 ↗ |
| 2010-06-08 | S-1/A | S-1/A (amendment) | ALDAGEN INC | 0001193125-10-135041 ↗ |
| 2010-07-02 | S-1/A | S-1/A (amendment) | ALDAGEN INC | 0001193125-10-153479 ↗ |
| 2011-04-05 | RW | RW (withdrawal request) | ALDAGEN INC | 0001193125-11-088464 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2010-07-02 | S-1/A | registration statement | $80.00 | - | - | Nasdaq ALDH.U | 2 | primary document; price sentence, cover names 2 | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2012-01-13 | ALDAGEN INC | Biotechnology | $645,004 | $585,004 | 13 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | ALDAGEN, INC. | NC | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | ALDAGEN INC | NC | Form D private offerings | CIK (EXACT) |
| Form 5500 plan sponsor | ALDAGEN, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NC first:
- FENNEC PHARMACEUTICALS INC. NC
- TENGION INC NC
- Chelsea Therapeutics International, Ltd. NC
- AERIE PHARMACEUTICALS INC NC
- PRECISION BIOSCIENCES INC NC
- Axium Pharmaceuticals Inc. NC
- Immunovant, Inc. NC
- Humacyte, Inc. NC
- PROKIDNEY CORP. NC
- Pelthos Therapeutics Inc. NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health